Title and Organization:
Dr. Bernal-Mizrachi is an assistant professor of hematology and medical oncology at Emory University School of Medicine and chair of research committee and quality improvement initiatives at Georgia Cancer Center for Excellence at Grady Memorial Hospital in Atlanta, Georgia. In addition, Dr. Bernal-Mizrachi is the chief scientific officer of Kodikaz Therapeutics, Inc., a research and development company focused on identifying genetic companion diagnostics and gene delivery technologies. Leon has served on the Committee on Promoting Diversity and leads the Ambassador Program at the American Society of Hematology, and he is a member of the Health Disparities Committee at the American Society of Clinical Oncology. Leon has received multiple research awards, including the Multiple Myeloma Research Foundation Accelerator Award, and has been recognized as one of the Best Doctors in America for several years. A hematologist and oncologist by training, his research focuses on employing high throughput genome scale data to discover molecular mechanisms for drug targeting and biomarkers for clinical applications in cancer. He has been involved in several genetic studies in B cell lymphomas and has published widely in high impact medical journals. Leon earned his MD at Universidad del Valle in Colombia. He completed his residency training at Miller School of Medicine at the University of Miami, followed by a hematology and medical oncology fellowship at Washington University in St. Louis, MO. Additionally, Leon trained in statistical analysis of genome scale data courses at Cold Spring Harbor Laboratory and in quality improvement at the American Society of Clinical Oncology. Leon is a Fellow of the fourth class of the Health Innovators Fellowship and a member of the Aspen Global Leadership Network.